Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01175031 · ClinicalTrials.gov registry record · NA
Comparison of Breathing Event Detection by a Continuous Positive Airway Pressure Device to Clinical Polysomnography
A NA study of Obstructive Sleep Apnea and Cheyne-Stokes Respiration, sponsored by Philips Respironics.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 3
- Study locations
NCT01175031: Completed NA study of Obstructive Sleep Apnea and Cheyne-Stokes Respiration, sponsored by Philips Respironics.
NCT01175031 is a NA study of Obstructive Sleep Apnea and Cheyne-Stokes Respiration that has completed, run by Philips Respironics. The registered enrollment target is 45 participants, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (80% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01175031, a NA study of Obstructive Sleep Apnea and Cheyne-Stokes Respiration, has completed, sponsored by Philips Respironics.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to demonstrate diagnostic agreement and determine the accuracy of the continuous positive airway pressure (CPAP) device compared to simultaneous, attended clinical polysomnography (PSG) in identifying breathing events in participants previously diagnosed with complex sleep apnea (CompSAS), complex sleep apnea with Cheyne-Stokes respiration (CSR), or obstructive sleep apnea (OSA).
Primary Outcome
The following breathing events: RERAs, central apneas, periodic breathing, obstructive apneas, and hypopneas in patients previously diagnosed with CompSAS or OSA detected by simultaneous Polysomnography and REMstar Auto with A-Flex were compared.
Conditions Studied
Interventions
- OTHER Manipulation of Positive Airway Pressure (PAP)
Study Locations (3)
Colorado
- National Jewish Health - Denver
Florida
- University of Florida - Shands Sleep Disorders Center - Gainesville
Michigan
- Sleep Health - Portage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2010-09 |
| Est. Completion | 2013-09 |
| Phase | NA |
What the finished NCT01175031 record still lists
NCT01175031 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (80% lower).
The record links to 3 conditions, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 1 intervention - of which Manipulation of Positive Airway Pressure (PAP) is the first listed.
NCT01175031 reports a single indexed study location in Colorado, Florida, Michigan.
Frequently Asked Questions
What is clinical trial NCT01175031 about?
NCT01175031 is a clinical study titled "Comparison of Breathing Event Detection by a Continuous Positive Airway Pressure Device to Clinical Polysomnography". The purpose of this study is to demonstrate diagnostic agreement and determine the accuracy of the continuous positive airway pressure (CPAP) device compared to simultaneous, attended clinical polysomnography (PSG) in identifying breathing events in participants previously diagnosed with complex sle...
What is the current status of trial NCT01175031?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2010-09. Estimated completion is 2013-09.
What conditions does trial NCT01175031 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea, Cheyne-Stokes Respiration, Sleep Apnea Central.
What interventions are being tested in trial NCT01175031?
The interventions under investigation include: Manipulation of Positive Airway Pressure (PAP) (OTHER).
Who is sponsoring clinical trial NCT01175031?
This trial is sponsored by Philips Respironics, which has 35 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01175031 being conducted?
This trial has 3 study locations across Colorado, Florida, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01175031's enrollment target sits among peer trials
45 110th of 155 higher than 46 of 155 other Obstructive Sleep Apnea trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obstructive Sleep Apnea trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
RECRUITING · NA
-
Cognition After OSA Treatment Among Native American People (CATNAP)
RECRUITING · NA
-
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
RECRUITING · NA
-
Mandibular Advancement Device and Changes in Nocturia
RECRUITING · NA
-
Severe Label Expansion for EVO Products Trial
RECRUITING · NA
-
App-Based Optimization of Long-Term CPAP Adherence and Quality of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia